Currently Viewing:
Community Oncology Alliance
Rose Gerber's Outlook on the Evolution and Goals of COA'S CPAN
July 13, 2017
Dr Barbara McAneny Discusses the Continuing Evolution of the COME HOME Model
July 07, 2017
Dr Basit Chaudhry on the Impact of the Oncology Care Model
July 05, 2017
Rose Gerber Discusses Cancer Survivorship's Lifelong Side Effects
June 30, 2017
Dr Bobby Green Explains How Changing Oncology Landscape Drives Big Data Initiatives
June 23, 2017
Leah Ralph on the Political and Legal Obstacles to 340B Reform
June 20, 2017
Leah Ralph: ACCC Concerned About Potential Impact of MedPAC Proposals
May 28, 2017
Dr Daniel George on the Challenge of Cancer Vaccines
May 04, 2017
Big Data Is Advancing Cancer Care, but Interoperability Remains a Challenge
May 03, 2017
Leah Ralph on ACCC's Concerns With GOP Healthcare Reform Proposals
April 30, 2017
Linking Claims, Clinical Data Is Essential for a Learning Health System
April 28, 2017
Dr Basit Chaudhry: Feedback Provides Potential Changes for the OCM
April 28, 2017
Christian Downs on the Importance of Developing the Oncology Workforce
April 28, 2017
Currently Reading
Oncologists Believe Achieving Cancer Moonshot Goals Should Start in the Community
April 28, 2017
Rose Gerber: Cancer Patients Made Their Voices Heard on Capitol Hill
April 27, 2017
Congressman, Pharmacist, and Lawyer Debate PBMs, Drug Prices at Annual COA Meeting
April 27, 2017
Dr Barbara McAneny on Leveling the Playing Field for Community Oncology
April 27, 2017

Oncologists Believe Achieving Cancer Moonshot Goals Should Start in the Community

Surabhi Dangi-Garimella, PhD
Community oncologists believe that they are in a very good position to lead the way to achieve the goals of Cancer Moonshot.
Vice President Joe Biden’s Cancer Moonshot initiative placed significant emphasis on the role of cancer centers in improving the nature of oncology care delivery in the country, ultimately to improve patient outcomes. However, community oncologists believe that they are in a very good position to lead the way.

Joining this discussion at the 2017 Community Oncology Conference, April 27-28, were William Harwin, MD, president and managing partner, Florida Cancer Specialists; Edward Licitra, MD, PhD, chief financial officer and director of revenue cycle, Central Jersey Division, Regional Cancer Care Associates (RCCA); and R. Steven Paulson, MD, President, Texas Oncology. Debra Patt, MD, MPH, MBA, vice president, Texas Oncology, moderated the discussion.

When asked about the role played by each of the practices in fueling Cancer Moonshot, Harwin said that there are many different factors that can influence Cancer Moonshot, including developing a patient care system. “We have about 50 patient managers, many of whom work remotely. We also have an active phase 1 unit on site, and that’s one of our biggest initiatives.”

As a result of requirements of the Oncology Care Model (OCM), Harwin's organization also has a care management team. “They are available 24 hours and provide triage, which is very valuable for our patients,” he added. The care management team, Harwin added, adhere to protocols developed for triage management and psychosocial support.

Paulson noted, however, that the challenge with OCM is the upfront investment for additional staffing requirements, to ensure reporting requirements and change implementation can be met. Paulson also addressed the importance of extending clinic hours to avoid emergency room visits.

“OCM has given us the ability to focus and change culture,” Licitra emphasized. He explained that the changes that a practice infuses to meet OCM requirements are not restricted to Medicare patients, rather, they extend to other patient populations as well. “While it is a work in progress, we are trying to centralize our processes,” he said, adding that RCCA is working with Innovative Oncology Business Solutions, co-founded by Barbara McAneny, MD, to bring this about.

“How important is research for your practice and how you have you built in in your practice?” Patt asked the panelists.

Licitra noted the importance of data integration to improve patient outcomes. RCCA is assembling all the genomics and proteomics information on patients and then trying to identify ways to improve outcomes. “We are using tools to understand both clinical and financial outcomes,” he added.

“We need people to realize the value of community oncology and they come to us and give us the opportunity to care for them,” Licitra said.

Paulson explained that Texas Oncology has built relations with hospitals, clinics, and the pharmaceutical industry to help support their in-house research efforts. “We try to create a situation where the best molecules are accessible to our patients,” he said.

He is, however, concerned with the low rate of clinical trial enrollment, especially among newly diagnosed patients.



 
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!